CPC A61B 5/0031 (2013.01) [A61B 5/076 (2013.01); A61B 5/279 (2021.01); A61B 5/686 (2013.01); A61B 6/4258 (2013.01); A61B 8/0808 (2013.01); A61B 8/085 (2013.01); A61B 8/0875 (2013.01); A61B 8/48 (2013.01); A61N 1/3605 (2013.01); A61N 1/37205 (2013.01); A61N 1/3787 (2013.01); B06B 1/06 (2013.01); G01N 27/327 (2013.01); A61B 2505/05 (2013.01); A61B 2560/0219 (2013.01); A61B 2562/028 (2013.01); A61B 2562/12 (2013.01); A61M 39/0208 (2013.01); A61M 2205/04 (2013.01); A61M 2205/825 (2013.01); A61N 1/0534 (2013.01); A61N 1/372 (2013.01); A61N 5/1071 (2013.01); A61N 2005/1087 (2013.01); A61N 2007/0021 (2013.01)] | 41 Claims |
1. An implantable device, comprising:
an ultrasonic transducer configured to receive ultrasonic waves, wherein the ultrasonic waves power the implantable device and comprise a trigger signal encoded in the ultrasonic waves, and wherein the ultrasonic transducer is further configured to emit ultrasonic backscatter waves, wherein information associated with the implantable device is encoded in the ultrasonic backscatter waves;
a first electrode and a second electrode configured to be in electrical communication with a tissue and emit an electrical pulse to the tissue in response to the trigger signal; and
an integrated circuit comprising an energy storage circuit.
|